Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AndroGel for Men with MDD and Low Testosterone
NCT00304746Phase 4Completed
- Sponsor
- McLean Hospital
- Start
- Apr 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing AndroGel with Placebo (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 9 weeks. Started Apr 2006; status: completed.
02
Drugs
AndroForte
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00304746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304746.